Intended for healthcare professionals

Letters News story on Tamiflu study

Principal author of PRIDE study responds to news story in The BMJ claiming that the study was based on “flawed” analysis

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2935 (Published 29 April 2014) Cite this as: BMJ 2014;348:g2935
  1. Jonathan S Nguyen-Van-Tam, clinical professor of health protection, and senior author, PRIDE Consortium1
  1. 1University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK
  1. jonathan.van-tam{at}nottingham.ac.uk

On 19 March 2014, researchers from the PRIDE (Post-pandemic Review of anti-Influenza Drug Effectiveness) Consortium published the first outputs from a project investigating the effectiveness of neuraminidase inhibitors against outcomes of public health importance during the 2009 flu pandemic in the Lancet Respiratory Medicine.1 2 The headline results suggested that neuraminidase inhibitors were associated with statistically significant reductions in mortality: overall adjusted odds ratio 0.81 (95% CI 0.70 to 0.93; P=0.0024) versus no treatment and 0.50 …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription